Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours
- PMID: 11762360
- DOI: 10.1093/annonc/12.suppl_2.s95
Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours
Abstract
Gastroenteropancreatic (GEP) neoplasms originate from any of the various cell types belonging to the neuroendocrine system. A general characteristic of GEP endocrine tumours is that the vast majority produce and secrete a multitude of peptide hormones and amines. Many patients with malignant metastasising tumours present clinical symptoms related to hormone hyperproduction. These include the so-called carcinoid syndrome, characterised by flushing, diarrhoea, wheezing and right heart disease, which is predominantly associated with the serotonin- and tachykinins-producing carcinoids of the midgut. Several types of syndrome associated with GEP endocrine tumors are caused by overproduction of a specific hormone. For instance, the well-known Zollinger-Ellison syndrome is gastrin-mediated. The so-called 'insulinoma syndrome' depends on excessive production of insulin and proinsulin, resulting in hypoglycemia. The 'glucagonoma syndrome' is characterised by necrolytic migratory erythema, diabetes and diarrhoea. The Verner-Morrison syndrome, which is brought about by high circulating levels of vasointestinal peptide (VIP). produces severe secretory diarrhoea. Finally the 'somatostatinoma syndrome' involves gallbladder dysfunction and gallstones, diarrhoea with or without steatorrhea, and impaired glucose tolerance. The biochemical diagnosis of endocrine digestive tumors is based on general and specific markers. The best general markers are chromogranin A (CgA) and pancreatic polypeptide (PP). Specific markers for endocrine tumors include insulin, gastrin, glucagon, vaso intestinal polypeptide (VIP), somatostatin and the primary cathabolic product of serotonin, 5-hydroxyndoleacetic acid (5-HIAA). Localisation procedures commonly applied, in the diagnosis of endocrine tumours include ultrasound (US), computed tomography (CT) and somatostatin receptor scintigraphy (SRS).
Similar articles
-
Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs).Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):791-802. doi: 10.1016/j.bpg.2012.12.006. Best Pract Res Clin Gastroenterol. 2012. PMID: 23582919 Review.
-
Tumor markers in neuroendocrine tumors.Digestion. 2000;62 Suppl 1:33-8. doi: 10.1159/000051853. Digestion. 2000. PMID: 10940685 Review.
-
Tumour markers in neuroendocrine tumours.Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S160-2. Ital J Gastroenterol Hepatol. 1999. PMID: 10604122 Review.
-
Biochemistry of neuroendocrine tumours.Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):33-41. doi: 10.1016/j.beem.2006.12.002. Best Pract Res Clin Endocrinol Metab. 2007. PMID: 17382264 Review.
-
Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.Ann Oncol. 2001;12 Suppl 2:S69-72. doi: 10.1093/annonc/12.suppl_2.s69. Ann Oncol. 2001. PMID: 11762355
Cited by
-
Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.Endocr Relat Cancer. 2008 Jun;15(2):409-27. doi: 10.1677/ERC-07-0221. Endocr Relat Cancer. 2008. PMID: 18508996 Free PMC article. Review.
-
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors.Neuroendocrinology. 2017;105(3):245-254. doi: 10.1159/000461583. Epub 2017 Mar 2. Neuroendocrinology. 2017. PMID: 28253514 Free PMC article.
-
Found in feces: differential diagnosis, workup, and treatment.Prim Care Companion CNS Disord. 2012;14(3):PCC.12f01341. doi: 10.4088/PCC.12f01341. Epub 2012 Jun 21. Prim Care Companion CNS Disord. 2012. PMID: 23106032 Free PMC article. No abstract available.
-
Carcinoid Crisis: A Misunderstood and Unrecognized Oncological Emergency.Cancers (Basel). 2022 Jan 28;14(3):662. doi: 10.3390/cancers14030662. Cancers (Basel). 2022. PMID: 35158931 Free PMC article. Review.
-
Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases.World J Gastroenterol. 2003 Apr;9(4):858-61. doi: 10.3748/wjg.v9.i4.858. World J Gastroenterol. 2003. PMID: 12679948 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous